14
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Glucose-6-Phosphate Content in Mammalian Pancreatic β-Cells

      research-article

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Glucose-6-phosphate was measured in microdissected pancreatic islets obtained from obese-hyperglycemic mice. Exposure of the islets in a low glucose medium to the hypoglycemic sulfonylurea compound glibenclamide resulted in a significant decrease of glucose-6-phosphate. This effect might be due to uncoupling of the oxidative phosphorylation leading to an accelerated glycolytic rate. Under the same experimental conditions another stimulator of insulin release, dibutyryl cyclic 3,5-AMP, induced a slight increase in glucose-6-phosphate. Inhibition of the glucose-induced insulin release by epinephrine, diazoxide or omission of Ca<sup>+ +</sup> resulted in considerably elevated islet levels of glucose-6-phosphate. A reduced availability of Ca<sup>+ +</sup> may be a common denominator forthis effect on glucose-6-phosphate.

          Related collections

          Author and article information

          Journal
          HRE
          Horm Res Paediatr
          10.1159/issn.1663-2818
          Hormone Research in Paediatrics
          S. Karger AG
          1663-2818
          1663-2826
          1971
          1971
          21 November 2008
          : 2
          : 6
          : 371-377
          Affiliations
          Department of Histology, University of Umeå, Umeå
          Article
          178249 Hormones 1971;2:371–377
          10.1159/000178249
          b82f9704-4269-48e2-984c-d44fd0f79730
          © 1971 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          History
          Page count
          Pages: 7
          Categories
          Paper

          Endocrinology & Diabetes,Neurology,Nutrition & Dietetics,Sexual medicine,Internal medicine,Pharmacology & Pharmaceutical medicine
          Ca+ + ,Isolated islets,Glucose metabolism,Pancreatic <italic>β</italic>-cells,Diazoxide,Glucose-6-phosphate,Dibutyryl cyclic 3,5-AMP,Epinephrine,Glibenclamide

          Comments

          Comment on this article